FARALLON CAPITAL MANAGEMENT LLC — 13F Holdings & Portfolio
CIK 909661 · latest 13F-HR filed 2026-05-15
FARALLON CAPITAL MANAGEMENT LLC manages $883.7M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2025-12-31 13F-HR filing. Its largest disclosed positions are EXAS (73.61%), RNAM (26.39%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 2 new positions, exited 169, added to 0, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$883.7M
Long-equity book
2
Distinct positions
2025-12-31
Filed 2026-05-15
+2 / −169 / ↑0 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Exited Positions
- REVOLUTION MEDICINES INC$1.32B
- AMAZON COM INC$878.6M
- MICROSOFT CORP$868.0M
- AON PLC$811.0M
- BRIDGEBIO PHARMA INC$695.5M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $17.54B | 172 | 0000908834-26-000240 |
| 2025-12-31 | 2026-02-17 | $21.19B | 151 | 0000908834-26-000087 |
| 2025-12-31 | 2026-05-15 | $883.7M | 2 | 0000908834-26-000241 |
| 2025-09-30 | 2026-02-17 | $24.43B | 144 | 0000908834-26-000086 |